Leqembi® approved for IV maintenance treatment in China
Go back to Leqembi® approved for IV maintenance treatment in China| BARNES GROUP, Inc. (NYSE: B) | Delayed: 47.55 +1.28 (2.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $46.27 | 52 Week High | $44.27 | |||
| Open | $47.40 | 52 Week Low | $30.07 | |||
| Day High | $47.79 | P/E | 36.30 | |||
| Day Low | $46.93 | EPS | $1.31 | |||
| Volume | 7,470,469 | |||||
| BIOAMBER, Inc. (NASDAQ: BIOA) | Delayed: 9.61 -0.08 (0.83%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $9.69 | 52 Week High | $8.73 | |||
| Open | $9.78 | 52 Week Low | $2.86 | |||
| Day High | $9.92 | P/E | N/A | |||
| Day Low | $9.51 | EPS | $-3.82 | |||
| Volume | 228,092 | |||||
